Pharmafile Logo
Pharmafocus logo
Advanced Search
az

AstraZeneca to collaborate with Alchemab on prostate cancer research

May 6, 2021
AstraZeneca, prostate cancer

AstraZeneca have announced a new collaboration with Cambridge-based biotech company Alchemab, with the aim of accelerating prostate cancer research. Alchemab …

News

Canada first country to authorise Pfizer vaccine in children aged 12-15

May 6, 2021
COVID-19, Canada, Pfizer, Vaccine

Canada has become the first country to authorise the use of Pfizer’s COVID-19 vaccine for children aged between 12 and …

News
Moderna building

COVID-19: Moderna booster shots appear to increase immunity

May 6, 2021
COVID-19, COVID-19 vaccine, Moderna, covid news, pharma, pharma news

Moderna’s mRNA booster jabs for people already vaccinated against COVID-19 have shown positive initial data in a Phase II study …

News

Sanofi to collaborate with Stanford University in immunology research

May 6, 2021
Sanofi

Sanofi has entered into a three-year research collaboration with Stanford University School of Medicine, working to advance the understanding of …

News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

May 5, 2021
Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen more COVID-19 vaccine and treatment news: Moderna will supply up to 500 million jabs to …

News

Theramex releases Vitamin D gel aimed at women

May 5, 2021
Research and Development Theramex, osteoporosis, pharma, pharma news, vitamin d

Theramex has launched a new gel for Vitamin D deficiency, in the hope that it will particularly treat women experiencing …

News

UK government to invest £29.3 million on COVID-19 variant testing

May 5, 2021
Research and Development COVID-19, UK government, Vaccine, variants

The UK government has announced an investment of £29.3 million, on top of the £19.7 million already pledged, to be …

News
janssen_latest_logo_on_sign

Janssen submits MAA to EMA for novel CAR-T cell therapy

May 5, 2021
Research and Development EMA, EU, Janssen, multiple myeloma

Janssen have submitted a Marketing Authorisation Application (MAA) to the EMA seeking approval of cilta-cel, an investigational B cell maturation …

News

New HIV prevention drug application submitted to FDA

May 5, 2021
Research and Development FDA, HIV

ViiV Healthcare have initiated a rolling submission of a new drug application (NDA) with the FDA for their long-acting HIV …

News

AstraZeneca drug approved by FDA for kidney disease treatment

May 4, 2021
Manufacturing and Production AstraZeneca, FDA, kidney disease, pharma, pharma news

AstraZeneca’s Farxiga drug has been approved for the treatment of chronic kidney disease (CKD) in the US by the FDA.

News

NICE finds more SMA patients eligible for £75,000 a vial drug

May 4, 2021
Manufacturing and Production, Sales and Marketing NICE, sma

NICE has announced that more people with the rare genetic disorder spinal muscular atrophy (SMA) are to benefit from nusinersen, …

News

Novartis eye treatment for diabetics shows positive results in Phase III trial

May 4, 2021
Manufacturing and Production DME, Novartis, diabetic macular edema, macular edema, pharma, pharma news

Novartis’ Beovu treatment for diabetic macular edema (DME) – an eye condition that can cause blindness – has shown positive …

News

Needle-free pandemic influenza vaccine sees preclinical proof-of-concept

May 4, 2021
Manufacturing and Production, Sales and Marketing Vaccine technology

Enesi Pharma, a US biotechnology company developing novel vaccination products, announced the development of a solid-dose recombinant H7N9 pandemic influenza …

News
moderna_norwood_plant

Moderna to supply up to 500 million COVID-19 vaccines to COVAX

May 4, 2021
Manufacturing and Production, Sales and Marketing COVAX, COVID-19, Moderna, Vaccine, WHO

Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …

News
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

April 30, 2021
Medical Communications COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news

Among our top 10 stories this week: In COVID news, an app has revealed the most common side effects for …

News

Celltrion’s COVID-19 treatment shows promise against South African variant

April 30, 2021
Medical Communications COVID-19, celltrion, covid 19 news, covid-19 news, covid-19 treatment, pharma, pharma news

Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according …

News

Melanoma market to reach $7.4bn by 2029

April 30, 2021
Medical Communications melanoma

A report from GlobalData, Melanoma – Global Drug Forecast and Market Analysis to 2029, has predicted the melanoma industry will …

News

Scipher Medicine to expand into autoimmune disease therapeutics

April 30, 2021
Medical Communications AI, autoimmune diseases

Scipher Medicine, a precision immunology company, announced the launch on Scipher Therapeutics on Thursday, marking the company’s shift towards the …

News

Positive phase III results achieved for dialysis drug in China

April 30, 2021
Medical Communications China, Kideny disease

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced positive results from a phase-III study in China (PA-CL-CHINA-01), evaluating the …

News
Takeda building

Takeda’s lung cancer drug granted FDA priority review

April 29, 2021
FDA, Takeda, lung cancer treatment, pharma, pharma news

The FDA has granted priority review for Takeda’s New Drug Application (NDA) for its mobocertinib drug for the treatment of …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026